ENANTA PHARMACEUTICALS INC ENTA on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001177648
0001177648
EIN:
04-3205099
04-3205099
LEI:
(CF Office: 03 Life Sciences)
Business address:
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Phone: 617 607 0800
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Phone: 617 607 0800
Mailing address:
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Filings:
750 EDGAR filings since June 21, 2002
750 EDGAR filings since June 21, 2002
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 17, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 5.07 - Submission of Matters to a Vote of Security Holders
- 9.01 - Financial Statements and Exhibits
- February 14, 2025 - SCHEDULE 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 12, 2025 - 10-Q: Quarterly report for quarter ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 11, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
Selected Filings
[+] 8-K (current reports)
- March 17, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 5.07 - Submission of Matters to a Vote of Security Holders
- 9.01 - Financial Statements and Exhibits
- February 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 12, 2025 - 10-Q: Quarterly report for quarter ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 27, 2024 - 10-K: Annual report for year ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 7, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 8, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- January 27, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 14, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 14, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 14, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 11, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 22, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 750 entries
Data source:
CIK0001177648.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
